Company Information
USD
55.4
- (0.3%)
NYSE:ENOV, ENOVIS CORP
Industry: Specialty Industrial Machinery
End of Day: 1 May 2024 GMT-4
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
Address
2711 Centerville Road
Suite 400
Website
Classification
Sector
Industrials
Industry Group
Industrial Products
Industry
Specialty Industrial Machinery
Key Executives
Mr. A. Clayton Perfall
Director
Ms. Angela S. Lalor
Director
Mr. Bradley J. Tandy
General Counsel/Senior VP
Mr. Daniel A. Pryor
Executive VP, Divisional
Ms. Patricia A. Lang
Other Executive Officer/Senior VP
Mr. Rajiv Vinnakota
Director
Ms. Sharon L. Wienbar
Director
Mr. Liam J. Kelly
Director
Mr. Matthew L. Trerotola
CEO/Chairman of the Board/Director
Ms. Barbara W. Bodem
Director
Dr. Christine Ortiz, B.S.,M.S.,PhD
Director
Mr. Brady R. Shirley
COO/Director/President
Mr. Philip A. Okala
Director
Mr. John Kleckner
Chief Accounting Officer/Controller/Vice President
Mr. Phillip Benjamin Berry
CFO/Senior VP
Mr. Louie Vogt
President, Divisional
Mr. Terry D. Ross
President, Divisional
Ownership
Institution Holdings
T. Rowe Price Investment Management,Inc.
6,582,110 (12.051%)
BlackRock Inc
5,331,217 (9.761%)
Vanguard Group Inc
4,900,608 (8.972%)
T. Rowe Price
4,617,838 (8.455%)
Dimensional Fund Advisors, Inc.
3,193,699 (5.847%)
BlackRock Fund Advisors
2,789,966 (5.108%)
Diamond Hill Capital Management Inc
2,505,915 (4.588%)
Select Equity Group LP
2,453,469 (4.492%)
Dimensional Fund Advisors LP
2,397,282 (4.389%)
Davenport & Company LLC
1,879,425 (3.441%)
Funds Holdings
T. Rowe Price Mid-Cap Growth Fund
3,225,400 (5.905%)
T. Rowe Price US Mid-Cap Growth Equity
3,225,400 (5.905%)
Vanguard US Total Market Shares ETF
1,549,036 (2.836%)
Vanguard Total Stock Market Index Fund
1,549,036 (2.836%)
iShares Core S&P Mid-Cap ETF
1,512,378 (2.769%)
Vanguard Small Cap Index
1,254,739 (2.297%)
American Century Small Cap Value Fund
900,000 (1.648%)
American Century U.S. Small Cap Value
900,000 (1.648%)
Vanguard Small Cap Value Index Fund
858,581 (1.572%)
T. Rowe Price U.S. Mid-Cap Growth Eq Tr
780,300 (1.429%)
Make Smart Investment Choices